scholarly journals A Randomized, Phase 2 Trial of Docetaxel with or without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Relapsed or Metastatic Non–Small-Cell Lung Cancer

2014 ◽  
Vol 9 (7) ◽  
pp. 1031-1035 ◽  
Author(s):  
Benjamin Levy ◽  
Alexander Spira ◽  
Daniel Becker ◽  
Tracey Evans ◽  
Ian Schnadig ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Phase 2 ◽  
Phosphatidylinositol 3 Kinase ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Randomized Phase 2

scholarly journals Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer

Cancer ◽  
2015 ◽  
Vol 121 (18) ◽  
pp. 3298-3306 ◽  
Author(s):  
Karen L. Reckamp ◽  
Marianna Koczywas ◽  
Mihaela C. Cristea ◽  
Jonathan E. Dowell ◽  
He-Jing Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
High Dose ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Randomized Phase 2

scholarly journals Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

2016 ◽  
Vol 24 (8) ◽  
pp. 3495-3505 ◽  
Author(s):  
Koichi Takayama ◽  
Nobuyuki Katakami ◽  
Takuma Yokoyama ◽  
Shinji Atagi ◽  
Kozo Yoshimori ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document